ibrutinib,obinutuzumab,venetoclax
abbvie,janssen,roche
['cll13', 'cll', 'gaia']
prognostic markers from cll13/gaia trial- interesting ras/raf with shorter pfs after ven based therapy (i hadn t been routinely checking for these mutations) #ash22 
Associate clinical professor at UC Irvine focused on CLL/SLL and CHIP/CCUS/MDS. Animal and nature lover. Tweets are my own.